Akari Therapeutics Plc (AKTX) Shareholders’ equity 2022–2023
Akari Therapeutics Plc (AKTX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$229,000FY2023 · since FY2022: $1.8M → -$229,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$229,000 | -112.8% |
| FY2022 | $1.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice